Beta Drugs Ltd Performance
Day's Low
Day's High
₹1,943.05Day's Price Range₹1,992.8552 Week's Low
52 Week's High
₹60052-Week Price Range₹2,326
| Returns % | |
| 1 Month Return | -9.85 % |
| 3 Month Return | + 21.31 % |
| 1 Year Return | + 39.68 % |
| Market Stats | |
| Previous Close | ₹1,983.40 |
| Open | ₹1,980.00 |
| Volume | 3,900.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,906.80Cr |
Beta Drugs Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹1,906.80 Cr |
| P/B Ratio | 10.22 |
| EPS | 37.9 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 20.67 |
Beta Drugs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,906.80 Cr | 523.4% | 0.54 | ₹36 Cr | ₹295 Cr | |
| NA | ₹344.94 Cr | 42.45% | 0.74 | NA | NA | |
| NA | ₹28.64 Cr | 62.64% | 0.50 | NA | NA | |
| NA | ₹899.93 Cr | 545.94% | 0.65 | ₹23 Cr | ₹307 Cr | |
| NA | ₹122.43 Cr | -1.65% | 0.00 | ₹3 Cr | ₹103 Cr |
About Beta Drugs Ltd
Share Price: ₹1965.00 per share as on 02 Jan, 2025 04:02 PM
Market Capitalisation: ₹1,906.80Cr as of today
Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra
| Organisation | Beta Drugs Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Beta Drugs Ltd
Beta Drugs Secures Funding for Oncology Expansion - 27 Nov, 2024
Beta Drugs announced a Rs 117 crore investment from Healthquad Fund II to enhance its growth in the oncology market, aiming to be a top player in India.
Insights on Beta Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTFII Holding Unchanged
Foreign Institutions holdings remained unchanged at 1.16% of holdings in Nov 2024 quarter
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 66.73% of holdings in Nov 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 50.7% return, outperforming this stock by 11.0%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 31.95% to 31.94% in Nov 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, BETA stock has moved down by -9.9%
Beta Drugs Ltd Financials
Beta Drugs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 66.73% | 0.00 | |
| Foreign Institutions | 1.16% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 31.94% | ||
| Others | 0.17% | 3.00 |
Beta Drugs Ltd Key Indicators
Beta Drugs Ltd Technicals Summary
Bearish
Neutral
Bullish
Beta Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Beta Drugs Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Beta Drugs Ltd shares.
Beta Drugs Ltd (BETA) share price today is ₹1965
Beta Drugs Ltd is listed on NSE
Beta Drugs Ltd is not listed on BSE
- Today’s highest price of Beta Drugs Ltd is ₹1992.85.
- Today’s lowest price of Beta Drugs Ltd is ₹1943.05.
Today’s traded volume of Beta Drugs Ltd(BETA) is 3,900.00.
Today’s market capitalisation of Beta Drugs Ltd(BETA) is ₹1906.8Cr.
| Beta Drugs Ltd(BETA | Price |
|---|---|
52 Week High | ₹2326 |
52 Week Low | ₹600 |
Beta Drugs Ltd(BETA) share price is ₹1965. It is down -15.52% from its 52 Week High price of ₹2326
Beta Drugs Ltd(BETA) share price is ₹1965. It is up 227.50% from its 52 Week Low price of ₹600
| Beta Drugs Ltd(BETA | Returns |
|---|---|
1 Day Returns | -18.4% |
1 Month Returns | -9.85% |
3 Month Returns | 21.31% |
1 Year Returns | 39.68% |